Clinical Trial: Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: A Multi Center, Multi National, Open Label, Extension Study to Evaluate the Long-term Efficacy and Safety of BMN 044 (PRO044) in Subjects With Duchenne Muscular Dystrophy

Brief Summary: The aim of this study is to provide continuing access to BMN 044 treatment for subjects previously treated with BMN 044. The information gained from this study is expected to further characterize the efficacy and safety of BMN 044 over a longer treatment period.